ArticleFrontiers in pharmacology2023

Efficacy and safety of adalimumab biosimilar (HS016) in inflammatory bowel disease from the real-world study.

Fang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.